Obesity promotes Fumonisin B1 toxicity and induces hepatitis
L. Dopavogui, M. Regnier, A. Polizzi, Q. Ponchon, S. Smati, W. Klement, F. Lasserre, C. Lukowicz, Y. Lippi, A. Fougerat, J. Bertrand-Michel, C. Naylies, C. Canlet, L. Debrauwer, L. Gamet-Payrastre, , N. Loiseau
This study shows that obesity increases susceptibility to fumonisin B1 toxicity, leading to gut dysbiosis and severe liver inflammation.
bioRxiv · Jul 22, 2022 · PreprintPharmacology & Toxicology